Association Between 5-Alpha Reductase Inhibitor Use and the Risk of Depression: A Meta-Analysis
August 2020
in “
Urology Journal
”
Studysummary This meta-analysis concluded that 5α-reductase inhibitors may increase the risk of mild depression, particularly with dutasteride, in patients treated for benign prostatic hyperplasia and androgenic alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on europepmc.org →